1 Study Coverage
    1.1 Embolic Agents Product Introduction
    1.2 Market by Type
        1.2.1 Global Embolic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Liquid Embolic Agents
        1.2.3 Particulate Embolic Agents
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Embolic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Occlude Bleeding
        1.3.3 Oncotherapy
        1.3.4 Malignant Hypertension
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Embolic Agents Sales Estimates and Forecasts 2017-2028
    2.2 Global Embolic Agents Revenue Estimates and Forecasts 2017-2028
    2.3 Global Embolic Agents Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Embolic Agents Sales by Region
        2.4.1 Global Embolic Agents Sales by Region (2017-2022)
        2.4.2 Global Sales Embolic Agents by Region (2023-2028)
    2.5 Global Embolic Agents Revenue by Region
        2.5.1 Global Embolic Agents Revenue by Region (2017-2022)
        2.5.2 Global Embolic Agents Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Embolic Agents Sales by Manufacturers
        3.1.1 Global Top Embolic Agents Manufacturers by Sales (2017-2022)
        3.1.2 Global Embolic Agents Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Embolic Agents in 2021
    3.2 Global Embolic Agents Revenue by Manufacturers
        3.2.1 Global Embolic Agents Revenue by Manufacturers (2017-2022)
        3.2.2 Global Embolic Agents Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Embolic Agents Revenue in 2021
    3.3 Global Embolic Agents Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Embolic Agents Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Embolic Agents Sales by Type
        4.1.1 Global Embolic Agents Historical Sales by Type (2017-2022)
        4.1.2 Global Embolic Agents Forecasted Sales by Type (2023-2028)
        4.1.3 Global Embolic Agents Sales Market Share by Type (2017-2028)
    4.2 Global Embolic Agents Revenue by Type
        4.2.1 Global Embolic Agents Historical Revenue by Type (2017-2022)
        4.2.2 Global Embolic Agents Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Embolic Agents Revenue Market Share by Type (2017-2028)
    4.3 Global Embolic Agents Price by Type
        4.3.1 Global Embolic Agents Price by Type (2017-2022)
        4.3.2 Global Embolic Agents Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Embolic Agents Sales by Application
        5.1.1 Global Embolic Agents Historical Sales by Application (2017-2022)
        5.1.2 Global Embolic Agents Forecasted Sales by Application (2023-2028)
        5.1.3 Global Embolic Agents Sales Market Share by Application (2017-2028)
    5.2 Global Embolic Agents Revenue by Application
        5.2.1 Global Embolic Agents Historical Revenue by Application (2017-2022)
        5.2.2 Global Embolic Agents Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Embolic Agents Revenue Market Share by Application (2017-2028)
    5.3 Global Embolic Agents Price by Application
        5.3.1 Global Embolic Agents Price by Application (2017-2022)
        5.3.2 Global Embolic Agents Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Embolic Agents Market Size by Type
        6.1.1 North America Embolic Agents Sales by Type (2017-2028)
        6.1.2 North America Embolic Agents Revenue by Type (2017-2028)
    6.2 North America Embolic Agents Market Size by Application
        6.2.1 North America Embolic Agents Sales by Application (2017-2028)
        6.2.2 North America Embolic Agents Revenue by Application (2017-2028)
    6.3 North America Embolic Agents Market Size by Country
        6.3.1 North America Embolic Agents Sales by Country (2017-2028)
        6.3.2 North America Embolic Agents Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Embolic Agents Market Size by Type
        7.1.1 Europe Embolic Agents Sales by Type (2017-2028)
        7.1.2 Europe Embolic Agents Revenue by Type (2017-2028)
    7.2 Europe Embolic Agents Market Size by Application
        7.2.1 Europe Embolic Agents Sales by Application (2017-2028)
        7.2.2 Europe Embolic Agents Revenue by Application (2017-2028)
    7.3 Europe Embolic Agents Market Size by Country
        7.3.1 Europe Embolic Agents Sales by Country (2017-2028)
        7.3.2 Europe Embolic Agents Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Embolic Agents Market Size by Type
        8.1.1 Asia Pacific Embolic Agents Sales by Type (2017-2028)
        8.1.2 Asia Pacific Embolic Agents Revenue by Type (2017-2028)
    8.2 Asia Pacific Embolic Agents Market Size by Application
        8.2.1 Asia Pacific Embolic Agents Sales by Application (2017-2028)
        8.2.2 Asia Pacific Embolic Agents Revenue by Application (2017-2028)
    8.3 Asia Pacific Embolic Agents Market Size by Region
        8.3.1 Asia Pacific Embolic Agents Sales by Region (2017-2028)
        8.3.2 Asia Pacific Embolic Agents Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Embolic Agents Market Size by Type
        9.1.1 Latin America Embolic Agents Sales by Type (2017-2028)
        9.1.2 Latin America Embolic Agents Revenue by Type (2017-2028)
    9.2 Latin America Embolic Agents Market Size by Application
        9.2.1 Latin America Embolic Agents Sales by Application (2017-2028)
        9.2.2 Latin America Embolic Agents Revenue by Application (2017-2028)
    9.3 Latin America Embolic Agents Market Size by Country
        9.3.1 Latin America Embolic Agents Sales by Country (2017-2028)
        9.3.2 Latin America Embolic Agents Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Embolic Agents Market Size by Type
        10.1.1 Middle East and Africa Embolic Agents Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Embolic Agents Revenue by Type (2017-2028)
    10.2 Middle East and Africa Embolic Agents Market Size by Application
        10.2.1 Middle East and Africa Embolic Agents Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Embolic Agents Revenue by Application (2017-2028)
    10.3 Middle East and Africa Embolic Agents Market Size by Country
        10.3.1 Middle East and Africa Embolic Agents Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Embolic Agents Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Medtronic
        11.1.1 Medtronic Corporation Information
        11.1.2 Medtronic Overview
        11.1.3 Medtronic Embolic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Medtronic Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Medtronic Recent Developments
    11.2 Terumo
        11.2.1 Terumo Corporation Information
        11.2.2 Terumo Overview
        11.2.3 Terumo Embolic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Terumo Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Terumo Recent Developments
    11.3 Boston Scientific
        11.3.1 Boston Scientific Corporation Information
        11.3.2 Boston Scientific Overview
        11.3.3 Boston Scientific Embolic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Boston Scientific Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Boston Scientific Recent Developments
    11.4 Merit Medical
        11.4.1 Merit Medical Corporation Information
        11.4.2 Merit Medical Overview
        11.4.3 Merit Medical Embolic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Merit Medical Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Merit Medical Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Corporation Information
        11.5.2 Johnson & Johnson Overview
        11.5.3 Johnson & Johnson Embolic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Johnson & Johnson Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Johnson & Johnson Recent Developments
    11.6 GEM Italy
        11.6.1 GEM Italy Corporation Information
        11.6.2 GEM Italy Overview
        11.6.3 GEM Italy Embolic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 GEM Italy Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 GEM Italy Recent Developments
    11.7 IMBiotechnologies Ltd?IMB?
        11.7.1 IMBiotechnologies Ltd?IMB? Corporation Information
        11.7.2 IMBiotechnologies Ltd?IMB? Overview
        11.7.3 IMBiotechnologies Ltd?IMB? Embolic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 IMBiotechnologies Ltd?IMB? Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 IMBiotechnologies Ltd?IMB? Recent Developments
    11.8 Emboflu
        11.8.1 Emboflu Corporation Information
        11.8.2 Emboflu Overview
        11.8.3 Emboflu Embolic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Emboflu Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Emboflu Recent Developments
    11.9 BTG
        11.9.1 BTG Corporation Information
        11.9.2 BTG Overview
        11.9.3 BTG Embolic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 BTG Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 BTG Recent Developments
    11.10 Cook Medical
        11.10.1 Cook Medical Corporation Information
        11.10.2 Cook Medical Overview
        11.10.3 Cook Medical Embolic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Cook Medical Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Cook Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Embolic Agents Industry Chain Analysis
    12.2 Embolic Agents Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Embolic Agents Production Mode & Process
    12.4 Embolic Agents Sales and Marketing
        12.4.1 Embolic Agents Sales Channels
        12.4.2 Embolic Agents Distributors
    12.5 Embolic Agents Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Embolic Agents Industry Trends
    13.2 Embolic Agents Market Drivers
    13.3 Embolic Agents Market Challenges
    13.4 Embolic Agents Market Restraints
14 Key Findings in The Global Embolic Agents Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Embolic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Liquid Embolic Agents
    Table 3. Major Manufacturers of Particulate Embolic Agents
    Table 4. Major Manufacturers of Others
    Table 5. Global Embolic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Embolic Agents Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Embolic Agents Sales by Region (2017-2022) & (K Units)
    Table 8. Global Embolic Agents Sales Market Share by Region (2017-2022)
    Table 9. Global Embolic Agents Sales by Region (2023-2028) & (K Units)
    Table 10. Global Embolic Agents Sales Market Share by Region (2023-2028)
    Table 11. Global Embolic Agents Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Embolic Agents Revenue Market Share by Region (2017-2022)
    Table 13. Global Embolic Agents Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Embolic Agents Revenue Market Share by Region (2023-2028)
    Table 15. Global Embolic Agents Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Embolic Agents Sales Share by Manufacturers (2017-2022)
    Table 17. Global Embolic Agents Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Embolic Agents Revenue Share by Manufacturers (2017-2022)
    Table 19. Embolic Agents Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Embolic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Embolic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolic Agents as of 2021)
    Table 22. Embolic Agents Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Embolic Agents Product Offered
    Table 24. Date of Manufacturers Enter into Embolic Agents Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Embolic Agents Sales by Type (2017-2022) & (K Units)
    Table 27. Global Embolic Agents Sales by Type (2023-2028) & (K Units)
    Table 28. Global Embolic Agents Sales Share by Type (2017-2022)
    Table 29. Global Embolic Agents Sales Share by Type (2023-2028)
    Table 30. Global Embolic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Embolic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Embolic Agents Revenue Share by Type (2017-2022)
    Table 33. Global Embolic Agents Revenue Share by Type (2023-2028)
    Table 34. Embolic Agents Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Embolic Agents Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Embolic Agents Sales by Application (2017-2022) & (K Units)
    Table 37. Global Embolic Agents Sales by Application (2023-2028) & (K Units)
    Table 38. Global Embolic Agents Sales Share by Application (2017-2022)
    Table 39. Global Embolic Agents Sales Share by Application (2023-2028)
    Table 40. Global Embolic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Embolic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Embolic Agents Revenue Share by Application (2017-2022)
    Table 43. Global Embolic Agents Revenue Share by Application (2023-2028)
    Table 44. Embolic Agents Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Embolic Agents Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Embolic Agents Sales by Type (2017-2022) & (K Units)
    Table 47. North America Embolic Agents Sales by Type (2023-2028) & (K Units)
    Table 48. North America Embolic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Embolic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Embolic Agents Sales by Application (2017-2022) & (K Units)
    Table 51. North America Embolic Agents Sales by Application (2023-2028) & (K Units)
    Table 52. North America Embolic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Embolic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Embolic Agents Sales by Country (2017-2022) & (K Units)
    Table 55. North America Embolic Agents Sales by Country (2023-2028) & (K Units)
    Table 56. North America Embolic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Embolic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Embolic Agents Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Embolic Agents Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Embolic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Embolic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Embolic Agents Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Embolic Agents Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Embolic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Embolic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Embolic Agents Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Embolic Agents Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Embolic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Embolic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Embolic Agents Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Embolic Agents Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Embolic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Embolic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Embolic Agents Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Embolic Agents Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Embolic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Embolic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Embolic Agents Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Embolic Agents Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Embolic Agents Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Embolic Agents Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Embolic Agents Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Embolic Agents Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Embolic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Embolic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Embolic Agents Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Embolic Agents Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Embolic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Embolic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Embolic Agents Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Embolic Agents Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Embolic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Embolic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Embolic Agents Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Embolic Agents Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Embolic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Embolic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Embolic Agents Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Embolic Agents Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Embolic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Embolic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Embolic Agents Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Embolic Agents Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Embolic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Embolic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Medtronic Corporation Information
    Table 107. Medtronic Description and Major Businesses
    Table 108. Medtronic Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Medtronic Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Medtronic Recent Developments
    Table 111. Terumo Corporation Information
    Table 112. Terumo Description and Major Businesses
    Table 113. Terumo Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Terumo Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Terumo Recent Developments
    Table 116. Boston Scientific Corporation Information
    Table 117. Boston Scientific Description and Major Businesses
    Table 118. Boston Scientific Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Boston Scientific Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Boston Scientific Recent Developments
    Table 121. Merit Medical Corporation Information
    Table 122. Merit Medical Description and Major Businesses
    Table 123. Merit Medical Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Merit Medical Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Merit Medical Recent Developments
    Table 126. Johnson & Johnson Corporation Information
    Table 127. Johnson & Johnson Description and Major Businesses
    Table 128. Johnson & Johnson Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Johnson & Johnson Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Johnson & Johnson Recent Developments
    Table 131. GEM Italy Corporation Information
    Table 132. GEM Italy Description and Major Businesses
    Table 133. GEM Italy Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. GEM Italy Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. GEM Italy Recent Developments
    Table 136. IMBiotechnologies Ltd?IMB? Corporation Information
    Table 137. IMBiotechnologies Ltd?IMB? Description and Major Businesses
    Table 138. IMBiotechnologies Ltd?IMB? Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. IMBiotechnologies Ltd?IMB? Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. IMBiotechnologies Ltd?IMB? Recent Developments
    Table 141. Emboflu Corporation Information
    Table 142. Emboflu Description and Major Businesses
    Table 143. Emboflu Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Emboflu Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Emboflu Recent Developments
    Table 146. BTG Corporation Information
    Table 147. BTG Description and Major Businesses
    Table 148. BTG Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. BTG Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. BTG Recent Developments
    Table 151. Cook Medical Corporation Information
    Table 152. Cook Medical Description and Major Businesses
    Table 153. Cook Medical Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Cook Medical Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Cook Medical Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Embolic Agents Distributors List
    Table 159. Embolic Agents Customers List
    Table 160. Embolic Agents Market Trends
    Table 161. Embolic Agents Market Drivers
    Table 162. Embolic Agents Market Challenges
    Table 163. Embolic Agents Market Restraints
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Embolic Agents Product Picture
    Figure 3. Global Embolic Agents Market Share by Type in 2021 & 2028
    Figure 3. Liquid Embolic Agents Product Picture
    Figure 4. Particulate Embolic Agents Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Embolic Agents Market Share by Application in 2021 & 2028
    Figure 7. Occlude Bleeding
    Figure 8. Oncotherapy
    Figure 9. Malignant Hypertension
    Figure 10. Others
    Figure 11. Embolic Agents Report Years Considered
    Figure 12. Global Embolic Agents Sales 2017-2028 (K Units)
    Figure 13. Global Embolic Agents Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Embolic Agents Revenue 2017-2028 (US$ Million)
    Figure 15. Global Embolic Agents Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Embolic Agents Sales Market Share by Region (2017-2022)
    Figure 17. Global Embolic Agents Sales Market Share by Region (2023-2028)
    Figure 18. North America Embolic Agents Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Embolic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Embolic Agents Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Embolic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Embolic Agents Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Embolic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Embolic Agents Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Embolic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Embolic Agents Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Embolic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Embolic Agents Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Embolic Agents in the World: Market Share by Embolic Agents Revenue in 2021
    Figure 30. Global Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Embolic Agents Sales Market Share by Type (2017-2028)
    Figure 32. Global Embolic Agents Revenue Market Share by Type (2017-2028)
    Figure 33. Global Embolic Agents Sales Market Share by Application (2017-2028)
    Figure 34. Global Embolic Agents Revenue Market Share by Application (2017-2028)
    Figure 35. North America Embolic Agents Sales Market Share by Type (2017-2028)
    Figure 36. North America Embolic Agents Revenue Market Share by Type (2017-2028)
    Figure 37. North America Embolic Agents Sales Market Share by Application (2017-2028)
    Figure 38. North America Embolic Agents Revenue Market Share by Application (2017-2028)
    Figure 39. North America Embolic Agents Sales Share by Country (2017-2028)
    Figure 40. North America Embolic Agents Revenue Share by Country (2017-2028)
    Figure 41. U.S. Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Embolic Agents Sales Market Share by Type (2017-2028)
    Figure 44. Europe Embolic Agents Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Embolic Agents Sales Market Share by Application (2017-2028)
    Figure 46. Europe Embolic Agents Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Embolic Agents Sales Share by Country (2017-2028)
    Figure 48. Europe Embolic Agents Revenue Share by Country (2017-2028)
    Figure 49. Germany Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 50. France Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Embolic Agents Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Embolic Agents Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Embolic Agents Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Embolic Agents Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Embolic Agents Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Embolic Agents Revenue Share by Region (2017-2028)
    Figure 60. China Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 63. India Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Embolic Agents Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Embolic Agents Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Embolic Agents Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Embolic Agents Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Embolic Agents Sales Share by Country (2017-2028)
    Figure 75. Latin America Embolic Agents Revenue Share by Country (2017-2028)
    Figure 76. Mexico Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Embolic Agents Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Embolic Agents Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Embolic Agents Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Embolic Agents Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Embolic Agents Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Embolic Agents Revenue Share by Country (2017-2028)
    Figure 85. Turkey Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Embolic Agents Revenue (2017-2028) & (US$ Million)
    Figure 88. Embolic Agents Value Chain
    Figure 89. Embolic Agents Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed